Recommendations for the Use of Clinical Data in Premarket Notification [510(k)] Submissions: Draft Guidance for Industry and Food and Drug Administration Staff

Information

Type

Guidance

Regulated products

Biologics, Medical Devices

Topics

Premarket

Published

September 7, 2023

Last updated

September 6, 2023

Description

Draft guidance document for industry and FDA staff on using clinical data in premarket notification submissions.

Organization

Country / Region

United States

License

Other (Public Domain)

Feedback

Suggest an improvement to this page

Actions

Social networks

Embed